Pharmacy Practice in Focus: Oncology
April 2026
Volume: 8
Issue: 3
February 2026
January 2026
Volume: 8
Issue: 1
December 2025
Volume: 7
Issue: 8
October 2025
Volume: 7
Issue: 7
August 2025
Volume: 7
Issue: 6
July 2025
Volume: 7
Issue: 5
June 2025
Volume: 7
Issue: 4
April 2025
Volume: 7
Issue: 3
February 2025
Volume: 7
Issue: 2
January 2025
Volume: 7
Issue: 1
December 2024
Volume: 6
Issue: 8
October 2024
Volume: 6
Issue: 7
August 2024
Volume: 6
Issue: 6
July 2024
Volume: 6
Issue: 5
June 2024
Volume: 6
Issue: 4
April 2024
Volume: 6
Issue: 3
February 2024
Volume: 6
Issue: 2
January 2024
Volume: 6
Issue: 1
December 2023
Volume: 5
Issue: 8
October 2023
Volume: 5
Issue: 6
August 2023
Volume: 5
Issue: 6
July 2023
Volume: 5
Issue: 5
June 2023
Volume: 5
Issue: 4
April 2023
Volume: 5
Issue: 3
February 2023
Volume: 5
Issue: 2
January 2023
Volume: 5
Issue: 1
December 2022
Volume: 4
Issue: 6
October 2022
Volume: 4
Issue: 5
August 2022
Volume: 4
Issue: 4
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADA 2026: Factors Associated With GLP-1 RA Nonresponse in T2D—and What Pharmacists Should Screen For
2
ADA 2026: Earlier GLP-1 and SGLT-2 Use Recommended From Diabetes Diagnosis, Expert Says
3
ADA 2026: Survodutide Cuts Visceral Fat and Normalizes Liver Fat in MASLD. Here's What the Data Mean for Metabolic Risk
4
The Hidden Reimbursement Crisis in Medicare’s Drug Price Negotiation Program
5